Jim Cramer - Mad Money
ChemoCentryx
CCXI-Q
DON'T BUY
Aug 15, 2022
A biotech with shares that more than doubled on a single day on a takeover bid by Biogen. At best, you'll make over a dollar per share if the deal goes ahead. If not, you will lose a fortune. Avoid.